Trends in use of high-risk medications for older veterans: 2004 to 2006
- PMID: 21883108
- PMCID: PMC3388719
- DOI: 10.1111/j.1532-5415.2011.03559.x
Trends in use of high-risk medications for older veterans: 2004 to 2006
Abstract
Objectives: To examine the change in use of high-risk medications for the elderly (HRME), as defined by the National Committee on Quality Assurance's Healthcare Effectiveness Data and Information Set (HEDIS) quality measure (HEDIS HRME), by older outpatient veterans over a 3-year period and to identify risk factors for HEDIS HRME exposure overall and for the most commonly used drug classes.
Design: Longitudinal retrospective database analysis.
Setting: Outpatient clinics within the Department of Veterans Affairs (VA).
Participants: Veterans aged 65 by October 1, 2003, and who received VA care at least once each year until September 30, 2006.
Measurements: Rates of use of HEDIS HRME overall and according to specific drug classes each year from fiscal year 2004 (FY04) to FY06.
Results: In a cohort of 1,567,467, high-risk medication exposure fell from 13.1% to 12.3% between FY04 and FY06 (P<.001). High-risk antihistamines (e.g., diphenhydramine), opioid analgesics (e.g., propoxyphene), skeletal muscle relaxants (e.g., cyclobenzaprine), psychotropics (e.g., long half-life benzodiazepines), endocrine (e.g., estrogen), and cardiac medications (e.g., short-acting nifedipine) had modest but statistically significant (P<.001) reductions (range -3.8% to -16.0%); nitrofurantoin demonstrated a statistically significant increase (+36.5%; P<.001). Overall HEDIS HRME exposure was more likely for men, Hispanics, those receiving more medications, those with psychiatric comorbidity, and those without prior geriatric care. Exposure was lower for individuals exempt from copayment. Similar associations were seen between ethnicity, polypharmacy, psychiatric comorbidity, access-to-care factors, and use of individual HEDIS HRME classes.
Conclusion: HEDIS HRME drug exposure decreased slightly in an integrated healthcare system. Risk factors for exposure were not consistent across drug groups. Future studies should examine whether interventions to further reduce HEDIS HRME use improve health outcomes.
© 2011, Copyright the Authors. Journal compilation © 2011, The American Geriatrics Society.
Figures
Similar articles
-
Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure.J Manag Care Pharm. 2006 Sep;12(7):537-45. doi: 10.18553/jmcp.2006.12.7.537. J Manag Care Pharm. 2006. PMID: 16981799 Free PMC article.
-
The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposure.Drugs Aging. 2013 Aug;30(8):645-54. doi: 10.1007/s40266-013-0086-8. Drugs Aging. 2013. PMID: 23645530 Free PMC article.
-
Influence of frailty-related diagnoses, high-risk prescribing in elderly adults, and primary care use on readmissions in fewer than 30 days for veterans aged 65 and older.J Am Geriatr Soc. 2014 Feb;62(2):291-8. doi: 10.1111/jgs.12656. Epub 2014 Jan 21. J Am Geriatr Soc. 2014. PMID: 24521365
-
Evidence Brief: The Quality of Care Provided by Advanced Practice Nurses [Internet].Washington (DC): Department of Veterans Affairs (US); 2014 Sep. Washington (DC): Department of Veterans Affairs (US); 2014 Sep. PMID: 27606392 Free Books & Documents. Review.
-
Functionally dependent veterans. Issues related to providing and improving their oral health care.Med Care. 1995 Nov;33(11 Suppl):NS143-63. Med Care. 1995. PMID: 7475426 Review.
Cited by
-
The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol.AIDS Behav. 2024 Oct 28. doi: 10.1007/s10461-024-04533-6. Online ahead of print. AIDS Behav. 2024. PMID: 39465468
-
Use of Muscle Relaxants After Surgery in Traditional Medicare Part D Enrollees.Drugs Aging. 2024 Jul;41(7):615-622. doi: 10.1007/s40266-024-01124-x. Epub 2024 Jul 9. Drugs Aging. 2024. PMID: 38980644 Free PMC article.
-
Health care system costs related to potentially inappropriate medication use involving opioids in older adults in Canada.BMC Health Serv Res. 2023 Nov 24;23(1):1295. doi: 10.1186/s12913-023-10303-2. BMC Health Serv Res. 2023. PMID: 38001466 Free PMC article.
-
Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study.Lancet Healthy Longev. 2021 Oct;2(10):e639-e650. doi: 10.1016/S2666-7568(21)00206-3. Epub 2021 Sep 29. Lancet Healthy Longev. 2021. PMID: 34870254 Free PMC article.
-
Factors associated with potentially inappropriate prescriptions and barriers to medicines optimisation among older adults in primary care settings: a systematic review.Fam Med Community Health. 2021 Nov;9(4):e001325. doi: 10.1136/fmch-2021-001325. Fam Med Community Health. 2021. PMID: 34794961 Free PMC article. Review.
References
-
- Fick DM, Waller JL, Maclean JR, et al. Potentially inappropriate medication use in a Medicare managed care population with higher costs and utilization. J Manag Care Pharm. 2001;7:407–413.
-
- Zhan C, Correa-de-Araujo R, Bierman AS, et al. Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations. J Am Geriatr Soc. 2005;53:262–267. - PubMed
-
- Blalock SJ, Byrd JE, Hansen RA, et al. Factors associated with potentially inappropriate drug utilization in a sample of rural community-dwelling older adults. Am J Geriatr Pharmacother. 2005;3:168–179. - PubMed
-
- Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother. 2006;4:134–143. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG034056/AG/NIA NIH HHS/United States
- R01 AG027017/AG/NIA NIH HHS/United States
- DHI-09-237/VA/VA/United States
- R34 MH082682/MH/NIMH NIH HHS/United States
- R01 HS017695/HS/AHRQ HHS/United States
- R01NR010135/NR/NINR NIH HHS/United States
- R01AG034056/AG/NIA NIH HHS/United States
- T32 AG021885/AG/NIA NIH HHS/United States
- K07AG033174/AG/NIA NIH HHS/United States
- K07 AG033174/AG/NIA NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- R01HS017695/HS/AHRQ HHS/United States
- R01 NR010135/NR/NINR NIH HHS/United States
- R56 AG027017/AG/NIA NIH HHS/United States
- P30AG024827/AG/NIA NIH HHS/United States
- R01AG027017/AG/NIA NIH HHS/United States
- R01 NR010828/NR/NINR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
